Research LettersWhole-body positron emission tomography in patients with HIV-1 infection
References (5)
- et al.
Whole body positron emission tomography imaging of activated lymphoid tissues during acute SHIV89.6PD infection in rhesus macaques
Virology
(2000) - et al.
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy
Nat Med
(1998)
Cited by (74)
PET imaging in HIV patients
2022, Nuclear Medicine and Molecular Imaging: Volume 1-4Positron Emission Tomography (PET) Imaging in Tuberculosis
2022, Nuclear Medicine and Molecular Imaging: Volume 1-4Contribution of <sup>18</sup>fluoro-deoxyglucose PET/CT for the diagnosis of infectious diseases
2014, Medecine et Maladies InfectieusesCitation Excerpt :However, we think that 18FDG-PET/CT is the procedure of choice for the diagnosis of this very severe infection when CT-scan is inconclusive, although data comparing 18FDG-PET/CT and radiolabeled leukocyte scintigraphy is still lacking for this type of infection. 18FDG-PET/CT was evaluated in many other infectious diseases: in tuberculosis to monitor early therapeutic response [50,51], in intensive care units to rule out important infections in mechanically ventilated patients [52], in HIV infection to determine lymphoid tissue activation [53] or to discriminate between cerebral toxoplasmosis and cerebral lymphoma [54], etc. However, the authors of these studies provided very limited and preliminary data and 18FDG-PET/CT should be used in those indications only in clinical trial settings and not routinely.
FDG-PET imaging in HIV infection and tuberculosis
2013, Seminars in Nuclear MedicineCitation Excerpt :Increased tissue FDG uptake preceded fulminant virus replication at these sites, suggesting that a diffusible factor of host or viral origin was responsible for lymphoid tissue changes. In humans, Scharko et al31 performed FDG-PET imaging in 15 patients suffering from HIV-1. They observed distinct lymphoid tissue activation in the head and neck during acute disease, a generalized pattern of peripheral LN activation at midstages, and involvement of abdominal LNs during late disease, suggesting that lymphoid tissues are engaged in a predictable sequence.